CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Barclays Adjusts Price Target on HCA Healthcare to $402 From $427, Maintains Equalweight Rating

Negative
AI Analysis

Summary

Barclays reduced its price target for HCA Healthcare from $427 to $402 while maintaining an Equalweight rating, indicating a slightly negative view on the stock.

Importance:2/10
Sentiment:
-0.30
price_target_adjustmentequity_researchdowngrade
Related Companies

Read the original article

Published by yahoo_finance on July 15, 2026 12:16 PM

Read Original